[
  {
    "ts": null,
    "headline": "S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments",
    "summary": "The S&P 500 rose 0.4% on Wednesday, May 7, 2025, as investors reviewed the details of today’s Federal Reserve meeting and parsed comments by President Donald Trump on trade with China.",
    "url": "https://finnhub.io/api/news?id=d3727110ee7bcf2d7843e7ebe533ff77fb6730503d9cc041df9c54212de60b5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746652754,
      "headline": "S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments",
      "id": 134316602,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "The S&P 500 rose 0.4% on Wednesday, May 7, 2025, as investors reviewed the details of today’s Federal Reserve meeting and parsed comments by President Donald Trump on trade with China.",
      "url": "https://finnhub.io/api/news?id=d3727110ee7bcf2d7843e7ebe533ff77fb6730503d9cc041df9c54212de60b5c"
    }
  },
  {
    "ts": null,
    "headline": "Charles River to initiate a review amid  Elliott stake - Is a sale next?",
    "summary": "Investing.com -- Charles River Laboratories (NYSE:CRL) announced Wednesday it will appoint four new directors to its board and launch a comprehensive strategic review following a cooperation agreement with activist hedge fund Elliott Investment Management, the company’s largest shareholder. The changes will be overseen by a newly formed Strategic Planning and Capital Allocation Committee aimed at enhancing long-term shareholder value.",
    "url": "https://finnhub.io/api/news?id=3a055f88cc3365438ce70b540d43239db4a8ac297daa06dfd1e488758ed3794f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746649362,
      "headline": "Charles River to initiate a review amid  Elliott stake - Is a sale next?",
      "id": 134317638,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Investing.com -- Charles River Laboratories (NYSE:CRL) announced Wednesday it will appoint four new directors to its board and launch a comprehensive strategic review following a cooperation agreement with activist hedge fund Elliott Investment Management, the company’s largest shareholder. The changes will be overseen by a newly formed Strategic Planning and Capital Allocation Committee aimed at enhancing long-term shareholder value.",
      "url": "https://finnhub.io/api/news?id=3a055f88cc3365438ce70b540d43239db4a8ac297daa06dfd1e488758ed3794f"
    }
  },
  {
    "ts": null,
    "headline": "Why Are Charles River Laboratories (CRL) Shares Soaring Today",
    "summary": "Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 17.3% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts' organic revenue and EPS estimates, and featured a raise to full-year EPS guidance. Zooming out, we think this was a solid print.",
    "url": "https://finnhub.io/api/news?id=79bb4ff44730620aa483f8df5e875ad417c71edf4879904d590ede38c8ebb54d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746639861,
      "headline": "Why Are Charles River Laboratories (CRL) Shares Soaring Today",
      "id": 134317639,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 17.3% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts' organic revenue and EPS estimates, and featured a raise to full-year EPS guidance. Zooming out, we think this was a solid print.",
      "url": "https://finnhub.io/api/news?id=79bb4ff44730620aa483f8df5e875ad417c71edf4879904d590ede38c8ebb54d"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.",
    "summary": "The biotech said its largest investor would conduct a “strategic review” as revenue continued to decline.",
    "url": "https://finnhub.io/api/news?id=5fdfbf4b50e4fc7f8157103443f74948d342f4d0708f39a43ce43e45976b4357",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746634620,
      "headline": "Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.",
      "id": 134317640,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "The biotech said its largest investor would conduct a “strategic review” as revenue continued to decline.",
      "url": "https://finnhub.io/api/news?id=5fdfbf4b50e4fc7f8157103443f74948d342f4d0708f39a43ce43e45976b4357"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More",
    "summary": "U.S. equities were little changed at midday with the market focused on comments from the Federal Reserve coming later today.",
    "url": "https://finnhub.io/api/news?id=cccc713aa35feaafc5534a5a8e3a6d4adadceced80142d4960d80b94c7778c94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746633060,
      "headline": "Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More",
      "id": 134317476,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "U.S. equities were little changed at midday with the market focused on comments from the Federal Reserve coming later today.",
      "url": "https://finnhub.io/api/news?id=cccc713aa35feaafc5534a5a8e3a6d4adadceced80142d4960d80b94c7778c94"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript",
    "summary": "Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2025 Results Conference Call May 7, 2025 9:00 AM ETCompany ParticipantsTodd Spencer - Vice...",
    "url": "https://finnhub.io/api/news?id=acb311541592f3266abfab9adb49b29b9548fae36d25a4856eed7c5431635a28",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746629173,
      "headline": "Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript",
      "id": 134299935,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "CRL",
      "source": "SeekingAlpha",
      "summary": "Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2025 Results Conference Call May 7, 2025 9:00 AM ETCompany ParticipantsTodd Spencer - Vice...",
      "url": "https://finnhub.io/api/news?id=acb311541592f3266abfab9adb49b29b9548fae36d25a4856eed7c5431635a28"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Labs Stock Soars as Firm Shakes Up Board, Launches Review",
    "summary": "Charles River Laboratories stock surged 16% Wednesday morning as the medical testing company made changes to its board and announced a strategic review as it faced pressure from Elliott Investment Management.",
    "url": "https://finnhub.io/api/news?id=a6662ed981b4cb4fb5b8ee0c51df2302a150ef88a3927f5b1ae317b647f74599",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746627793,
      "headline": "Charles River Labs Stock Soars as Firm Shakes Up Board, Launches Review",
      "id": 134317642,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River Laboratories stock surged 16% Wednesday morning as the medical testing company made changes to its board and announced a strategic review as it faced pressure from Elliott Investment Management.",
      "url": "https://finnhub.io/api/news?id=a6662ed981b4cb4fb5b8ee0c51df2302a150ef88a3927f5b1ae317b647f74599"
    }
  },
  {
    "ts": null,
    "headline": "CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up",
    "summary": "Charles River delivers better-than-expected earnings and revenues in the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=b845ae14b9843f44da16a792f34f4ad5117fc1f223bcf221b13a43ec6f8f305e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746624900,
      "headline": "CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up",
      "id": 134316918,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River delivers better-than-expected earnings and revenues in the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=b845ae14b9843f44da16a792f34f4ad5117fc1f223bcf221b13a43ec6f8f305e"
    }
  },
  {
    "ts": null,
    "headline": "Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics",
    "summary": "The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finnhub.io/api/news?id=4bed8a911be12ee9ca793d1c0ae467311b0d4cc558285b98a291fc58f5592590",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746624636,
      "headline": "Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics",
      "id": 134317644,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
      "url": "https://finnhub.io/api/news?id=4bed8a911be12ee9ca793d1c0ae467311b0d4cc558285b98a291fc58f5592590"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%",
    "summary": "Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2.7% year on year to $984.2 million. Its non-GAAP profit of $2.34 per share was 12.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=d932e84ffc8b2699324209c74de3379ef908d65749669ceb97e0401a6e6429f8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746620361,
      "headline": "Charles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%",
      "id": 134317645,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2.7% year on year to $984.2 million. Its non-GAAP profit of $2.34 per share was 12.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=d932e84ffc8b2699324209c74de3379ef908d65749669ceb97e0401a6e6429f8"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates",
    "summary": "Charles River (CRL) delivered earnings and revenue surprises of 13.59% and 5.25%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=e9d0f7e8066a578226fe674811bfaaadade6a0d7ed0dc8bf0aab1a2e040bfe5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746620106,
      "headline": "Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates",
      "id": 134317646,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River (CRL) delivered earnings and revenue surprises of 13.59% and 5.25%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=e9d0f7e8066a578226fe674811bfaaadade6a0d7ed0dc8bf0aab1a2e040bfe5f"
    }
  },
  {
    "ts": null,
    "headline": "Charles River: Q1 Earnings Snapshot",
    "summary": "CRL) on Wednesday reported first-quarter profit of $25.5 million. On a per-share basis, the Wilmington, Massachusetts-based company said it had profit of 50 cents. Earnings, adjusted for one-time gains and costs, came to $2.34 per share.",
    "url": "https://finnhub.io/api/news?id=42a92932965ea593a5fd6106084a233ced9b9f1dd3a048aae9aa62887c4f6f04",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746616433,
      "headline": "Charles River: Q1 Earnings Snapshot",
      "id": 134317647,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "CRL) on Wednesday reported first-quarter profit of $25.5 million. On a per-share basis, the Wilmington, Massachusetts-based company said it had profit of 50 cents. Earnings, adjusted for one-time gains and costs, came to $2.34 per share.",
      "url": "https://finnhub.io/api/news?id=42a92932965ea593a5fd6106084a233ced9b9f1dd3a048aae9aa62887c4f6f04"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories Announces First-Quarter 2025 Results",
    "summary": "WILMINGTON, Mass., May 07, 2025--Charles River Laboratories Announces First-Quarter 2025 Financial Results",
    "url": "https://finnhub.io/api/news?id=21b21751dce63e8f6ff6e21c67a5991728558dfc7cfaef4e2b558657bfb0f0d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746615660,
      "headline": "Charles River Laboratories Announces First-Quarter 2025 Results",
      "id": 134317648,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "WILMINGTON, Mass., May 07, 2025--Charles River Laboratories Announces First-Quarter 2025 Financial Results",
      "url": "https://finnhub.io/api/news?id=21b21751dce63e8f6ff6e21c67a5991728558dfc7cfaef4e2b558657bfb0f0d7"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value",
    "summary": "WILMINGTON, Mass., May 07, 2025--Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value",
    "url": "https://finnhub.io/api/news?id=5fdac227c6a02f3a689038b68e8055b54fb8a0c5ffe28434743971f7a78a6694",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746615600,
      "headline": "Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value",
      "id": 134317649,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "WILMINGTON, Mass., May 07, 2025--Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value",
      "url": "https://finnhub.io/api/news?id=5fdac227c6a02f3a689038b68e8055b54fb8a0c5ffe28434743971f7a78a6694"
    }
  },
  {
    "ts": null,
    "headline": "Charles River raises 2025 profit forecast, reaches deal with activist investor",
    "summary": "(Reuters) -Charles River Laboratories shares jumped 15% on Wednesday after the company raised its annual profit forecast due to improving demand for contract drug research services.  Separately, the Massachusetts-based company also said that it had reached an agreement with activist investor Elliott Management.  Charles River's stock climbed to $133.36, though it has fallen approximately 37% year-to-date as the company and other contract drugmakers face sluggish demand among smaller biotech companies, negatively impacting their financial performance.",
    "url": "https://finnhub.io/api/news?id=15b30ea21a1a5d26c3dfec62b329ec3df1eb936bed2da1d33c8b861d20bfb093",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746612499,
      "headline": "Charles River raises 2025 profit forecast, reaches deal with activist investor",
      "id": 134317650,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "(Reuters) -Charles River Laboratories shares jumped 15% on Wednesday after the company raised its annual profit forecast due to improving demand for contract drug research services.  Separately, the Massachusetts-based company also said that it had reached an agreement with activist investor Elliott Management.  Charles River's stock climbed to $133.36, though it has fallen approximately 37% year-to-date as the company and other contract drugmakers face sluggish demand among smaller biotech companies, negatively impacting their financial performance.",
      "url": "https://finnhub.io/api/news?id=15b30ea21a1a5d26c3dfec62b329ec3df1eb936bed2da1d33c8b861d20bfb093"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories International to Initiate Comprehensive Review of its Business to Enhance Long-Term Stockholder Value",
    "summary": "Charles River Laboratories International, Inc. announced on May 7, 2025, that it had reached an agreement with activist investor Elliott Investment Management and added four new directors to its...",
    "url": "https://finnhub.io/api/news?id=b7f00648e2445c0861da904889d3e68007d213361117ebd66aa7505061e2d8a9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746608520,
      "headline": "Charles River Laboratories International to Initiate Comprehensive Review of its Business to Enhance Long-Term Stockholder Value",
      "id": 134296865,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "Charles River Laboratories International, Inc. announced on May 7, 2025, that it had reached an agreement with activist investor Elliott Investment Management and added four new directors to its...",
      "url": "https://finnhub.io/api/news?id=b7f00648e2445c0861da904889d3e68007d213361117ebd66aa7505061e2d8a9"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business",
    "summary": "Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business",
    "url": "https://finnhub.io/api/news?id=801d17f09eddeaf4cafe4d0a518612eb77b3e608787f5ae7df49e98550745715",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746604500,
      "headline": "Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business",
      "id": 134359557,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "Charles River Labs 1Q Earnings Rise, Ups FY Outlook; Board Will Conduct Strategic Review of Business",
      "url": "https://finnhub.io/api/news?id=801d17f09eddeaf4cafe4d0a518612eb77b3e608787f5ae7df49e98550745715"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Futures Rise in Premarket Trading; Sarepta Therapeutics, OneStream Lag",
    "summary": "S&P 500 Futures Rise in Premarket Trading; Sarepta Therapeutics, OneStream Lag",
    "url": "https://finnhub.io/api/news?id=bb0566056341a596744eef55f290b1830842d126d001fc76010e3cbd2f35116d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746603000,
      "headline": "S&P 500 Futures Rise in Premarket Trading; Sarepta Therapeutics, OneStream Lag",
      "id": 134299798,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "S&P 500 Futures Rise in Premarket Trading; Sarepta Therapeutics, OneStream Lag",
      "url": "https://finnhub.io/api/news?id=bb0566056341a596744eef55f290b1830842d126d001fc76010e3cbd2f35116d"
    }
  },
  {
    "ts": null,
    "headline": "Charles River to add new directors, review business in agreement with Elliott",
    "summary": "Charles River Laboratoriessaid on Wednesday it had reached an agreement with activistinvestor Elliott Investment Management and added four newdirectors to its board. Charles River's...",
    "url": "https://finnhub.io/api/news?id=d53cb6856e11f2f75bf9d568100ed046dbf431df1a4a83c84d25a0da35b98644",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746602946,
      "headline": "Charles River to add new directors, review business in agreement with Elliott",
      "id": 134293759,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "Charles River Laboratoriessaid on Wednesday it had reached an agreement with activistinvestor Elliott Investment Management and added four newdirectors to its board. Charles River's...",
      "url": "https://finnhub.io/api/news?id=d53cb6856e11f2f75bf9d568100ed046dbf431df1a4a83c84d25a0da35b98644"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories International : Q1 2025 Earnings Presentation",
    "summary": "Charles River Laboratories 1Q 2025 Results May 7, 2025 © 2025 Charles River Laboratories International,...",
    "url": "https://finnhub.io/api/news?id=bf6c18e17fb91879982d1ab1af43b5998ac00dab1d85998e835390c89ec8b870",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746602471,
      "headline": "Charles River Laboratories International : Q1 2025 Earnings Presentation",
      "id": 134293565,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "Charles River Laboratories 1Q 2025 Results May 7, 2025 © 2025 Charles River Laboratories International,...",
      "url": "https://finnhub.io/api/news?id=bf6c18e17fb91879982d1ab1af43b5998ac00dab1d85998e835390c89ec8b870"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories International : CRL 1Q25 Financial Reconciliations (05-07-25)",
    "summary": "‌1Q25‌ Regulation G Financial Reconciliations & Appendix © 2025 Charles River Laboratories...",
    "url": "https://finnhub.io/api/news?id=229d262153577d6ac6837b781eee8a1fd4e1c06d11fd45da3ef0fb847b4431a7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746602292,
      "headline": "Charles River Laboratories International : CRL 1Q25 Financial Reconciliations (05-07-25)",
      "id": 134293412,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "‌1Q25‌ Regulation G Financial Reconciliations & Appendix © 2025 Charles River Laboratories...",
      "url": "https://finnhub.io/api/news?id=229d262153577d6ac6837b781eee8a1fd4e1c06d11fd45da3ef0fb847b4431a7"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories International : CRL 1Q25 Earnings Release (05-07-25)",
    "summary": "NEWS RELEASE CHARLES RIVER LABORATORIES ANNOUNCES FIRST-QUARTER 2025 RESULTS First-Quarter Revenue of $984.2 Million - ...",
    "url": "https://finnhub.io/api/news?id=504ccfaf47f3df6793ff64271f5e9356e7ab0d79e96a346afc42676e687d9648",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746602292,
      "headline": "Charles River Laboratories International : CRL 1Q25 Earnings Release (05-07-25)",
      "id": 134293411,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "NEWS RELEASE CHARLES RIVER LABORATORIES ANNOUNCES FIRST-QUARTER 2025 RESULTS First-Quarter Revenue of $984.2 Million - ...",
      "url": "https://finnhub.io/api/news?id=504ccfaf47f3df6793ff64271f5e9356e7ab0d79e96a346afc42676e687d9648"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 29, 2025",
    "summary": "Charles River Laboratories International, Inc. reported earnings results for the first quarter ended March 29, 2025. For the first quarter, the company reported revenue was USD 984.17 million compared...",
    "url": "https://finnhub.io/api/news?id=11079768e06b25bd9e9dba6122c0f7c5357b563c127dff415c0fa1650c771d4c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746601740,
      "headline": "Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 29, 2025",
      "id": 134295137,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "Charles River Laboratories International, Inc. reported earnings results for the first quarter ended March 29, 2025. For the first quarter, the company reported revenue was USD 984.17 million compared...",
      "url": "https://finnhub.io/api/news?id=11079768e06b25bd9e9dba6122c0f7c5357b563c127dff415c0fa1650c771d4c"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories International, Inc. Revises Earnings Guidance for Year 2025",
    "summary": "Charles River Laboratories International, Inc. revised earnings guidance for year 2025. For the period, the company expects negative revenue growth of % ? % compared to % ?% previously; GAAP EPS...",
    "url": "https://finnhub.io/api/news?id=e7eb791c56421f0fed34e479f6171f55f9ded4c550ae8a360557428a52a0745a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746601260,
      "headline": "Charles River Laboratories International, Inc. Revises Earnings Guidance for Year 2025",
      "id": 134295716,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "Charles River Laboratories International, Inc. revised earnings guidance for year 2025. For the period, the company expects negative revenue growth of % ? % compared to % ?% previously; GAAP EPS...",
      "url": "https://finnhub.io/api/news?id=e7eb791c56421f0fed34e479f6171f55f9ded4c550ae8a360557428a52a0745a"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories International, Inc. Announces Board Changes",
    "summary": "Charles River Laboratories International, Inc. announced that four new directors will join its Board of Directors and that four long-time members of the Board will not seek re-election at the 2025...",
    "url": "https://finnhub.io/api/news?id=56e31891bafc3748746c7d9bc06392579db20caa56b978293d7347e55c8f569a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746601200,
      "headline": "Charles River Laboratories International, Inc. Announces Board Changes",
      "id": 134295736,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "Charles River Laboratories International, Inc. announced that four new directors will join its Board of Directors and that four long-time members of the Board will not seek re-election at the 2025...",
      "url": "https://finnhub.io/api/news?id=56e31891bafc3748746c7d9bc06392579db20caa56b978293d7347e55c8f569a"
    }
  }
]